PDCD1 and neoplasm: First, FGFR-TKI directly causes epigenetic alterations in T-cells, promotes T-cell lineage diversification, reduces T-cell PD-1 expression, intrinsically restores T-cell anti-tumor activity and prevents active T-cell death.